A research team led by Rice's Yang Gao has uncovered new insights into the molecular mechanisms of ADAR1. ADAR1 converts adenosine to inosine in double-stranded RNA, a process essential for preventing ...

Breakthroughs in RNA editing and radioligand therapies are poised to take biotech into a new era – driving innovation, growth and new investment opportunities Biotechnology is entering a dynamic new ...

This figure illustrates the evolution of CRISPR technology from 1987 to 2019, presented in a horizontal timeline format and categorized into four generations, each denoted by a distinct color: The ...

ゲノムは、自身が持っている遺伝子の発現を調節する方法を多数作り出してきた。今回、新しい発現調節機構がD Spectorらによって発見され、Cellに報告されている。彼らは、普段は核内に保留されているが、ストレスに応じて切断され、翻訳可能なmRNAとして ...

RNAレベルで遺伝情報が書き換えられるという論文が発表され、激しい論争が巻き起こっている。 奇妙な出来事はリボゾームへ向かう途中で起こった。メッセンジャーRNA（mRNA；細胞内でDNAからタンパク質合成装置まで情報を運ぶ仲介分子）が、その情報で ...

LEIDEN, Netherlands & CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based ...

These new preclinical platform data further highlight the potential of Axiomer EONs in preparation for clinical development and supporting discovery of potential new therapeutic applications. The ...

ProQR Therapeutics is advancing its Axiomer ADAR-mediated RNA editing pipeline, aiming to file a Clinical Trial Application for its lead program AX-0810, targeting NTCP for cholestatic diseases, by Q2 ...